Showing results (851-860 of 861) with videos related to
Sort By:
Pageof 87
Schizophrenia Research|August 16, 2008
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric studyE M Meisenzahl, N Koutsouleris, R Bottlender, et al.Molecular Psychiatry|November 15, 2008
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depressionT Frodl, N Koutsouleris, R Bottlender, et al.Proceedings of the National Academy of Sciences of the United States of America|January 9, 1996
Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescenceD R Sell, M A Lane, W A Johnson, et al.Journal of Synchrotron Radiation|March 2, 2021
Materials Imaging and Dynamics (MID) instrument at the European X-ray Free-Electron Laser FacilityA Madsen, J Hallmann, G Ansaldi, et al.Annals of Hematology|August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meetingM Witzens-Harig, G Hess, J Atta, et al.Leukemia|September 27, 2008
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)C Buske, E Hoster, M Dreyling, et al.ESMO Real World Data and Digital Oncology|April 3, 2026
Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine careL Sellmann, D Marschner, U M Martens, et al.Neuroradiology|April 11, 2002
Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumineD Balériaux, C Colosimo, J Ruscalleda, et al.Medical Physics|March 28, 2018
A preclinical Talbot-Lau prototype for x-ray dark-field imaging of human-sized objectsC Hauke, P Bartl, M Leghissa, et al.Radiology|June 1, 2000
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical studyJ Petersein, A Spinazzi, A Giovagnoni, et al.Pageof 87